Abstract
Objective
To investigate whether JNK-caspase-dependent apoptotic pathway is involved in Aβ31–35-induced apoptosis of cultured cortical neurons.
Methods
Cultured cortical neurons were treated with Aβ31–35 (25 µmol/L) for 4 h, 8 h, 16 h and 24 h, respectively. Caspase activities were measured using a spectrophotometer. Levels of c-Jun phosphorylation (p-c-Jun) and Fas ligand (FasL) expression were assessed by immunocytochemistry method and quantified using Image-pro plus11.0 image processing and analysis software.
Results
Treatment with Aβ31–35 (25 µmol/L) for 24 h induced significant increases in the activities of caspase-3 and caspase-8 in the cortical neurons. Besides, Aβ31–35 could time-dependently enhance the expression of p-c-Jun protein. Moreover, SP600125 application (100 nmol/L) could completely abolish Aβ31–35 neurotoxicity. The increase in FasL expression was detected at 8 h, 16 h and 24 h after Aβ31–35 treatment, and SP600125 (100 nmol/L) significantly inhibited FasL expression.
Conclusion
JNK-c-Jun-FasL-caspase-dependent extrinsic apoptotic pathway plays a critical role in mediating Aβ31–35-induced apoptosis of cultured neurons.
Keywords: Aβ31–35, neurotoxicity, caspase, JNK pathway
摘要
目的
探讨JNK信号通路在Aβ31–35诱导的神经元凋亡过程中的作用。
方法
经老化处理的Aβ31–35 (终浓度为25 µmol/L)制备AD 细胞模型, 采用生物比色法检测caspase-3和caspase-8 的活性。 采用免疫细胞化学技术观察不同时间点磷酸化c-Jun (p-c-Jun)及Fas ligand (FasL) 蛋白的表达情况, 并用IPP11.0图像分析软件进行定量分析。
结果
Aβ31–35 孵育24 h能显著提高神经元内caspase-3和caspase-8的活性。 Aβ31–35孵育4 h时p-c-Jun蛋白表达水平开始升高, 在8h升高最显著, 呈现一定的时间依赖性; JNK特异性抑制剂SP600125能抑制Aβ31–35对p-c-Jun蛋白表达的诱导作用。 Aβ31–35孵育8 h时出现FasL蛋白表达的升高, 而SP600125则能抑制这一作用。
结论
JNK激活的外源性凋亡途径在Aβ31–35诱导的神经元凋亡过程中发挥一定的作用。
关键词: Aβ31–35, 神经毒性, caspase, JNK通路
References
- [1].Yankner B.A., Duffy L.K., Kirschner D.A. Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides. Science. 1990;250:279–282. doi: 10.1126/science.2218531. [DOI] [PubMed] [Google Scholar]
- [2].Golde T.E. The Aβ hypothesis: leading us to rationally-designed therapeutic strategies for the treatment or prevention of Alzheimer disease. Brain Pathol. 2005;15:84–87. doi: 10.1111/j.1750-3639.2005.tb00104.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [3].Estus S., Tucker H.M., van Rooyen C., Wright S., Brigham E.F., Wogulis M., et al. Aggregated amyloid protein induces cortical neuronal apoptosis and concomitant “apoptosis” pattern of gene induction. J Neurosci. 1997;17:7736–7745. doi: 10.1523/JNEUROSCI.17-20-07736.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [4].Allen J.W., Eldadah B.A., Huang X., Knoblach S.M., Faden A.I. Multiple caspases are involved in beta-amyloid-induced neuronal apoptosis. J Neurosci Res. 2001;65:45–53. doi: 10.1002/jnr.1126. [DOI] [PubMed] [Google Scholar]
- [5].Qi J.S., Ye L., Qiao J.T. Amyloid β-protein fragment 31-35 suppresses delayed rectifying potassium channels in membrane patches excised from hippocampal neurons in rats. Synapse. 2004;51:165–172. doi: 10.1002/syn.10299. [DOI] [PubMed] [Google Scholar]
- [6].Yan X.Z., Qiao J.T., Dou Y., Qiao Z.D. β-Amyloid fragment 31-35 induces apoptosis in cultured cortical neurons. Neuroscience. 1999;92:177–184. doi: 10.1016/S0306-4522(98)00727-1. [DOI] [PubMed] [Google Scholar]
- [7].Li L.M., Qiao J.T., Zhang C. Effects of humanin on elevation of intracellular calcium concentration induced by β-amyloid peptide 31-35 in cultured cortical neurons. Acta Physiologica Sinica. 2009;61:127–131. [PubMed] [Google Scholar]
- [8].Zhao L., Qian Z.M., Zhang C., Wing H.Y., Du F., Ya K. Amyloid β-peptide 31-35-induced neuronal apoptosis is mediated by caspasedependent pathways via cAMP-dependent protein kinase activation. Aging Cell. 2008;7:47–57. doi: 10.1111/j.1474-9726.2007.00352.x. [DOI] [PubMed] [Google Scholar]
- [9].Banasiak K.J., Xia Y., Haddad G.G. Mechanisms underlying hypoxia-induced neuronal apoptosis. Prog Neurobiol. 2000;62:215–249. doi: 10.1016/S0301-0082(00)00011-3. [DOI] [PubMed] [Google Scholar]
- [10].Castedo M., Prefettini J., Andreau K., Rounier T., Piacentini M., Kroemer G. Mitochondrial apoptosis induced by the HIVEnvelope. Ann N Y Acad Sci. 2003;1010:19–28. doi: 10.1196/annals.1299.004. [DOI] [PubMed] [Google Scholar]
- [11].Behrens A., Sibilis M., Wagner E.F. Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation. Nat Genet. 1999;21:326–329. doi: 10.1038/6854. [DOI] [PubMed] [Google Scholar]
- [12].Le-Niculescu H., Bonfoco E., Kasuya Y., Claret F.X., Green D.R., Karin M. Withdrawal of survival factors results in activation of the JNK pathway in neuronal cells leading to Fas ligand induction and cell death. Mol Cell Biol. 1999;19:751–763. doi: 10.1128/mcb.19.1.751. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [13].Troy C.M., Rabacchi S.A., Xu Z., Maroney A.C., Connors T.J., Shelanski M.L., et al. β-Amyloid-induced neuronal apoptosis requires c-Jun N-terminal kinase activation. J Neurochem. 2001;77:157–164. doi: 10.1046/j.1471-4159.2001.t01-1-00218.x. [DOI] [PubMed] [Google Scholar]
- [14].Yang D.D., Kuan C.Y., Whitmarsh A.J., Rincon M., Zheng T.S., Davis R.J., et al. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature. 1997;389:865–870. doi: 10.1038/39899. [DOI] [PubMed] [Google Scholar]
- [15].Wang Y., Gu Z.L., Qin Z.H. The role of caspase and calpain in neuronal apoptosis and pathogenesis of Huntington disease. Neurosci Bull. 2005;21:224–229. [Google Scholar]
- [16].Casley C.S., Land J.M., Sharpe M.A., Clark J.B., Duchen M.R., Canevari L. β-Amyloid fragment 25–35 causes mitochondrial dysfunction in primary cortical neurons. Neurobiol Dis. 2002;10:258–267. doi: 10.1006/nbdi.2002.0516. [DOI] [PubMed] [Google Scholar]
- [17].Wei W., Wang X., Kusiak J.W. Signaling events in amyloid β-peptide-induced neuronal death and IGF-I protection. J Biol Chem. 2002;277:17649–17656. doi: 10.1074/jbc.M111704200. [DOI] [PubMed] [Google Scholar]
- [18].Lu D.C., Shaked G.M., Masliah E., Bredesen D.E., Koo E.H. Amyloid beta protein toxicity mediated by the formation of amyloidbeta protein precursor complexes. Ann Neurol. 2003;54:781–789. doi: 10.1002/ana.10761. [DOI] [PubMed] [Google Scholar]
- [19].Matsui T., Ramasamy K., Ingelsson M., Fukumoto H., Conrad C., Frosch M.P., et al. Coordinated expression of caspase 8, 3 and 7 mRNA in temporal cortex of Alzheimer disease: relationship to formic acid extractable abeta42 levels. J Neuropathol Exp Neuro. 2006;65:508–515. doi: 10.1097/01.jnen.0000229238.05748.12. [DOI] [PubMed] [Google Scholar]
- [20].Herdegen T., Claret F.X., Kallunki T., Martin-Villalba A., Winter C., Hunter T., et al. Lasting N-terminal phosphorylation of c-Jun and activation of c-Jun N-terminal kinases after neuronal injury. J Neurosci. 1998;18:5124–5135. doi: 10.1523/JNEUROSCI.18-14-05124.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [21].Bennett B.L., Sasaki D.T., Murray B.W., O’Leary E.C., Sakata S.T., Xu W., et al. SP600125, an anthrapyrazolone inhibitor of Jun Nterminal kinase. Proc Natl Acad Sci U S A. 2001;98:13681–13686. doi: 10.1073/pnas.251194298. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [22].Hashimoto Y., Tsuji O., Niikura T., Yamagishi Y., Ishizaka M., Kawasumi M., et al. Involvement of c-Jun N-terminal kinase in amyloid precursor protein-mediated neuronal cell death. J Neurochem. 2003;84:864–877. doi: 10.1046/j.1471-4159.2003.01585.x. [DOI] [PubMed] [Google Scholar]
- [23].Martin-Villalba A., Herr I., Jeremias I., Hahne M., Brandt R., Vogel J., et al. CD95 ligand (Fas-L/ APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons. J Neurosci. 1999;19:3809–3817. doi: 10.1523/JNEUROSCI.19-10-03809.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [24].de la Monte S.M., Sohn Y.K., Ganju N., Wands J.R. Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer’s disease. J Neurol Sci. 1997;152:73–83. doi: 10.1016/S0022-510X(97)00131-7. [DOI] [PubMed] [Google Scholar]
- [25].Seidl R., Fang-Kircher S., Bidmon B., Cairns N., Lubec G. Apoptosisassociated proteins p53 and APO-1/Fas (CD95) in brains of adult patients with Down syndrome. Neurosci Lett. 1999;260:9–12. doi: 10.1016/S0304-3940(98)00945-8. [DOI] [PubMed] [Google Scholar]